<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04908449</url>
  </required_header>
  <id_info>
    <org_study_id>PRO00040365</org_study_id>
    <nct_id>NCT04908449</nct_id>
  </id_info>
  <brief_title>Pectointercostal Fascial Plane Block (PIFB) Alone Versus PIFB With Serratus Anterior Plane Block (SAPB) in Cardiac Surgery</brief_title>
  <official_title>A Comparison of the Analgesic Effects of Pectointercostal Fascial Plane Block (PIFB) Alone Versus PIFB With Serratus Anterior Plane Block (SAPB) in Cardiac Surgery: a Prospective, Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical College of Wisconsin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical College of Wisconsin</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if ultrasound-guided bilateral pectointercostal&#xD;
      fascial plane blocks with unilateral serratus anterior plane block decrease pain scores,&#xD;
      decrease opioid consumption, improve respiratory function, and improve quality of recovery in&#xD;
      patients recovering from coronary artery bypass surgery (CABG) in comparison to&#xD;
      pectointercostal fascial plane blocks alone.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single center, prospective, randomized, controlled, double-blinded study. We&#xD;
      anticipate recruitment of 50-60 subjects, with 25-30 in each group.&#xD;
&#xD;
      Primary Outcomes:&#xD;
&#xD;
      Pain scores on a 0-10 visual analog scale (VAS) at rest and with deep breathing at 1, 3, 6,&#xD;
      12, 18, and 24 hours post-extubation between subjects receiving PIFB + SAPB versus subjects&#xD;
      receiving only PIFB.&#xD;
&#xD;
      Total cumulative opioid consumption at 24 and 48 hours post-operatively.&#xD;
&#xD;
      Secondary Outcomes:&#xD;
&#xD;
        -  Intraoperative total opioid consumption&#xD;
&#xD;
        -  Change from baseline on incentive spirometry at 1, 3, 12, and 24 hours post-extubation&#xD;
&#xD;
        -  Time from ICU arrival to liberation from mechanical ventilation&#xD;
&#xD;
        -  QoR-15 (Quality of Recovery) score23 24 hours after extubation&#xD;
&#xD;
      Preoperative Management :&#xD;
&#xD;
      Subjects will be randomized on the morning of surgery to receive bilateral PIFB and left SAPB&#xD;
      with local anesthetic versus bilateral PIFB and left SAPB with saline (placebo).&#xD;
&#xD;
      Intraoperative Management All subjects will receive the standard of care anesthetic regimen&#xD;
      for their cardiac surgery.&#xD;
&#xD;
      Postoperative Management Each PIFB will be performed with 20 mL of 0.25% bupivacaine with 5&#xD;
      mcg/ml of epinephrine, and left-sided SAPB will be performed with an additional 20 mL of&#xD;
      0.25% bupivacaine with 5 mcg/ml of epinephrine or placebo.&#xD;
&#xD;
      Postoperative Evaluation:&#xD;
&#xD;
      Evaluation of acute postoperative pain intensity using a 0-10 visual analog scale (VAS) will&#xD;
      be undertaken at the following time points, both at rest and with deep breathing:&#xD;
&#xD;
      â€¢ 1, 3, 6, 12, 18, and 24 hours post-extubation Incentive spirometry will be assessed at 1,&#xD;
      3, 12, and 24 hours post-extubation, with three measures taken at each time point in order to&#xD;
      compare postoperative performance with baseline spirometry.&#xD;
&#xD;
      Review of the medical chart will be made post-operatively to gather other data, including&#xD;
      total intraoperative oral morphine equivalent consumption, cumulative opioid consumption at&#xD;
      24 and 48 hours, time from ICU arrival to tracheal extubation, and QoR-15 (Quality of&#xD;
      Recovery) score23 administered 24 hours after extubation (with margin of error of 18-30 hours&#xD;
      to avoid waking patients in the middle of the night) . Occurrences of any adverse events&#xD;
      reported by the subject or medical team will also be collected.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 2021</start_date>
  <completion_date type="Anticipated">August 2022</completion_date>
  <primary_completion_date type="Anticipated">July 2022</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain scores on a 0-10 visual analog scale at rest and with deep breathing</measure>
    <time_frame>1 hour post-extubation</time_frame>
    <description>Pain scores on a 0-10 visual analog scale at rest and with deep breathing</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain scores on a 0-10 visual analog scale at rest and with deep breathing</measure>
    <time_frame>3 hours post-extubation</time_frame>
    <description>Pain scores on a 0-10 visual analog scale at rest and with deep breathing</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain scores on a 0-10 visual analog scale at rest and with deep breathing</measure>
    <time_frame>6 hours post-extubation</time_frame>
    <description>Pain scores on a 0-10 visual analog scale at rest and with deep breathing</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain scores on a 0-10 visual analog scale at rest and with deep breathing</measure>
    <time_frame>12 hours post-extubation</time_frame>
    <description>Pain scores on a 0-10 visual analog scale at rest and with deep breathing</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain scores on a 0-10 visual analog scale at rest and with deep breathing</measure>
    <time_frame>18 hours post-extubation</time_frame>
    <description>Pain scores on a 0-10 visual analog scale at rest and with deep breathing</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain scores on a 0-10 visual analog scale at rest and with deep breathing</measure>
    <time_frame>24 hours post-extubation</time_frame>
    <description>Pain scores on a 0-10 visual analog scale at rest and with deep breathing</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total cumulative opioid consumption</measure>
    <time_frame>24 hours post-operatively</time_frame>
    <description>Total cumulative opioid consumption at 24 hours</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total cumulative opioid consumption</measure>
    <time_frame>48 hours post-operatively</time_frame>
    <description>Total cumulative opioid consumption at 48 hours</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intraoperative total opioid consumption</measure>
    <time_frame>From anesthesia start to anesthesia stop</time_frame>
    <description>Intraoperative total opioid consumption</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time from ICU arrival to liberation from mechanical ventilation</measure>
    <time_frame>ICU arrival until extubation</time_frame>
    <description>Time from ICU arrival to liberation from mechanical ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vital capacity change from baseline on incentive spirometry</measure>
    <time_frame>1 hour post-extubation</time_frame>
    <description>Vital capacity change from baseline on incentive spirometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vital capacity change from baseline on incentive spirometry</measure>
    <time_frame>3 hours post-extubation</time_frame>
    <description>Vital capacity change from baseline on incentive spirometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vital capacity change from baseline on incentive spirometry</measure>
    <time_frame>12 hours post-extubation</time_frame>
    <description>Vital capacity change from baseline on incentive spirometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vital capacity change from baseline on incentive spirometry</measure>
    <time_frame>24 hours post-extubation</time_frame>
    <description>Vital capacity change from baseline on incentive spirometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>QoR-15 (Quality of Recovery) score</measure>
    <time_frame>24 hours after extubation</time_frame>
    <description>QoR-15 (Quality of Recovery) score</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Postoperative Pain</condition>
  <condition>Respiratory Failure</condition>
  <arm_group>
    <arm_group_label>Serratus anterior plane block with PIFB (experimental arm)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PIFB with local anesthetic with SAPB with local anesthetic (bupivacaine)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Serratus anterior plane block with PIFB (placebo arm)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>PIFB with local anesthetic with SAPB placebo (saline)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Serratus anterior plane block with bupivacaine</intervention_name>
    <description>Serratus anterior plane block with local anesthetic versus sham block with saline</description>
    <arm_group_label>Serratus anterior plane block with PIFB (experimental arm)</arm_group_label>
    <arm_group_label>Serratus anterior plane block with PIFB (placebo arm)</arm_group_label>
    <other_name>Serratus anterior plane block with saline placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjects scheduled for cardiac surgery (CABG, CABG + single valve) involving primary&#xD;
             median sternotomy and left-sided pleural chest tube&#xD;
&#xD;
          -  Age 18-85 years of age&#xD;
&#xD;
          -  BMI 18-50 kg/m2&#xD;
&#xD;
          -  Weight &gt; 60 kg&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Left ventricular ejection fraction (LVEF) &lt; 30%&#xD;
&#xD;
          -  Preoperative, intraoperative, or immediate post-operative placement of intra-aortic&#xD;
             balloon pump or deployment of extra-corporeal membrane oxygenation (ECMO)&#xD;
&#xD;
          -  Inability to understand or speak English&#xD;
&#xD;
          -  Allergy to bupivacaine or other amide local anesthetic&#xD;
&#xD;
          -  Contraindication to peripheral nerve block (e.g. local infection, previous trauma to&#xD;
             the block site)&#xD;
&#xD;
          -  Chronic opioid consumption (daily oral morphine equivalent of &gt;20 mg) in the past&#xD;
             three months&#xD;
&#xD;
          -  Severe pulmonary or hepatic disease&#xD;
&#xD;
          -  Neurological deficit or disorder&#xD;
&#xD;
          -  Suspected or known addiction to or abuse of illicit drug(s), prescription medicine(s),&#xD;
             or alcohol within the past two years&#xD;
&#xD;
          -  Uncontrolled anxiety, schizophrenia, or other severe psychiatric disorder&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anne Castro</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical College of Wisconsin</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anne Castro, MD</last_name>
    <phone>414-805-2715</phone>
    <email>anncastro@mcw.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medical College of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 24, 2021</study_first_submitted>
  <study_first_submitted_qc>May 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 1, 2021</study_first_posted>
  <last_update_submitted>May 27, 2021</last_update_submitted>
  <last_update_submitted_qc>May 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical College of Wisconsin</investigator_affiliation>
    <investigator_full_name>Anne Castro, MD</investigator_full_name>
    <investigator_title>Assistant Professor of Anesthesiology</investigator_title>
  </responsible_party>
  <keyword>local anesthetic</keyword>
  <keyword>regional anesthesia</keyword>
  <keyword>quality of recovery</keyword>
  <keyword>postoperative pain</keyword>
  <keyword>coronary artery bypass graft</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

